NUT Midline Carcinoma (NMC)
1 clinical trials · Condition
◉ Watch NUT Midline Carcinoma (NMC)
| Record | Firm | Date |
|---|---|---|
| A Dose Exploration Study With Birabresib (MK-8628) in Participants With Selected Advanced Solid Tumors (MK-8628-006) (NCT02698176) | Merck Sharp & Dohme LLC | 2016-05-04 |
Track NUT Midline Carcinoma (NMC) automatically
Every clearance here is in the API, with alerts when new ones post.